EyePoint Pharmaceuticals, Inc. Quarterly Operating Lease, Payments in USD from Q1 2019 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
EyePoint Pharmaceuticals, Inc. annual/quarterly Operating Lease, Payments history and growth rate from Q1 2019 to Q3 2023.
  • EyePoint Pharmaceuticals, Inc. Operating Lease, Payments for the quarter ending September 30, 2023 was $274K, a 67.1% increase year-over-year.
  • EyePoint Pharmaceuticals, Inc. annual Operating Lease, Payments for 2023 was $1.4M, a 75% increase from 2022.
  • EyePoint Pharmaceuticals, Inc. annual Operating Lease, Payments for 2022 was $800K, a 13% decline from 2021.
  • EyePoint Pharmaceuticals, Inc. annual Operating Lease, Payments for 2021 was $920K, a 6.11% increase from 2020.
Operating Lease, Payments, Trailing 12 Months (USD)
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2023 $274K +$110K +67.1% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-03
Q1 2023 $703K $145K -$97K -40.1% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-04
Q4 2022 $800K $156K -$86K -35.5% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-08
Q3 2022 $886K $164K -$72K -30.5% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-03
Q2 2022 $958K $238K +$17K +7.69% Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-05
Q1 2022 $941K $242K +$21K +9.5% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 $920K $242K +$21K +9.5% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-10
Q3 2021 $899K $236K +$20K +9.26% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-04
Q2 2021 $879K $221K +$6K +2.79% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-05
Q1 2021 $873K $221K +$6K +2.79% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-06
Q4 2020 $867K $221K +$6K +2.79% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-14
Q3 2020 $861K $216K +$6K +2.86% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-05
Q2 2020 $855K $215K +$10K +4.88% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-06
Q1 2020 $845K $215K +$37K +20.8% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-05
Q4 2019 $808K $215K Oct 1, 2019 Dec 31, 2019 10-K 2021-03-12
Q3 2019 $210K Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-06
Q2 2019 $205K Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-05
Q1 2019 $178K Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.